Search

Search Constraints

You searched for: Author/Creator Pretta, Andrea

Search Results

1. BRAF-mutant colorectal cancer, a different breed evolving. (3rd June 2018)

2. Circulating DNA in the neoadjuvant setting of early stage colon cancer. (3rd October 2022)

3. Feasibility and clinical impact of routine molecular testing of gastrointestinal cancers at a tertiary centre with a multi-gene, tumor-agnostic, next generation sequencing panel. (1st December 2020)

4. Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib. Issue 6 (June 2021)

5. Influence of antidiabetic drugs on glucose metabolism and immune response in patients with metastatic pancreatic ductal adenocarcinoma receiving gemcitabine plus nab-paclitaxel as first-line treatment. Issue 5 (May 2023)

6. Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast?. (January 2021)

7. Molecular-driven treatment for biliary tract cancer: the promising turning point. Issue 11 (2nd November 2021)

8. Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters. (November 2022)

9. Rationale and design of REGINA, a phase II trial of neoadjuvant regorafenib, nivolumab, and short-course radiotherapy in stage II and III rectal cancer. (3rd April 2021)

10. Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus. Issue 6 (December 2021)